Agreement signedPublished 7 Apr 2026

Supernus Pharmaceuticals, Inc. /
Navitor Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. agrees to buy Navitor Pharmaceuticals, Inc.

Buy side: Supernus Pharmaceuticals, Inc.
Buy sideSupernus Pharmaceuticals, Inc.
Target: Navitor Pharmaceuticals, Inc.
TargetNavitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. · 7 Apr 2026Source
Buy side: Supernus Pharmaceuticals, Inc.
Buy sideSupernus Pharmaceuticals, Inc.
Target: Navitor Pharmaceuticals, Inc.
TargetNavitor Pharmaceuticals, Inc.
01 / BuyerSupernus Pharmaceuticals, Inc.
02 / TargetNavitor Pharmaceuticals, Inc.
Source for the buyer and target: Supernus Pharmaceuticals, Inc.

For the buyer and target.

“On April 1, 2026, Supernus Pharmaceuticals, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Agreement”), together with related ancillary transaction documents, with Navitor Pharmaceuticals, Inc., a Delaware corporation (“Navitor”), Navitor Pharmaceuticals, LLC, a Delaware limited liability company (“Navitor Parent,” and, together with Navitor, the “Sellers”).”

Published 7 Apr 2026

Open the source
01

What happened

Supernus Pharmaceuticals, Inc. agreed to acquire Navitor Pharmaceuticals, Inc. for up to $350 million, according to a filing dated April 7, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. agrees to buy Navitor Pharmaceuticals, Inc.

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “Supernus Pharmaceuticals, Inc. agrees to buy Navitor Pharmaceuticals, Inc. Supernus Pharmaceuticals, Inc. agreed to acquire Navitor Pharmaceuticals, Inc. for up to $350 million, according to a filing dated April 7, 2026”

    Open the source
  2. Published by Supernus Pharmaceuticals, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.